Skip to main content
Clinical Trials/JPRN-UMIN000024751
JPRN-UMIN000024751
Completed
未知

Examination of brain function improvement of plasmalogen intake. - The effect of plasmalogen on cognitive functions.

Shiba Palace Clinic0 sites60 target enrollmentNovember 8, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiba Palace Clinic
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 8, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 A person who possibly shows food allergy symptom. 2 A person who had been treated, hospitalized or operated for stroke, subarachnoid hemorrhage, cerebral infarction, cerebral haemorrhage, brain contusion or head trauma. 3 A person who is alcohol or nicotine addict, or whose dietary habit is extremely irregular. 4 A person with medical history or current illness of hepatic disorder. 5 A person with severe anemia. 6 A person with medical history of epileptic stroke, diabetes, thyroid dysfunction or severe renal dysfunction(hemodialysis, uremia, anuria), or attending the hospital regularly for these disorder. 7 A person who has taken a neuropsychological test at hospital. 8 A person who joins other human clinical study. 9 A person who is routinely taking medicines (e.g. antipsychotic, antianxiety agent, antidepressant, antiparkinson agent, antimanic agent, anticonvulsant, anticoagulant agent) which possibly affects the test results. 10 A person who is routinely taking health foods (supplements effective for antioxidative, blood flow\-ameliorating and so on) which possibly affects the test results. 11 A person who is judged inappropriate to join the study by doctor in charge. (Subject who is judged inappropriate during this test is excluded from targets of analysis. In addition, a criterion not in screening criteria is not included in exclusion criteria for screening.) 12 A person who have taken an RBANS test in 3 month before main test schedule.

Outcomes

Primary Outcomes

Not specified

Similar Trials